December 18, 2007 17:30 ET

ICPA Completes Successful Pilot Test of Automated Reporting of Healthcare-Associated Infections to the Centers for Disease Control

Infection Control and Prevention Analysts, Inc. (ICPA) Successfully Completed a Pilot Test to Transmit Hospital Infection Data From the AICE® Millennium Infection Control Software System to the CDC's National Healthcare Safety Network (NHSN)

AUSTIN, TX--(Marketwire - December 18, 2007) - In a pilot sponsored by the CDC, ICPA has successfully transmitted infection data from the AICE® Millennium commercial infection control software system to the CDC's NHSN. This pilot was the first field test of the Health Level Seven Clinical Document Architecture Release 2 (HL7 CDA R2) for public health reporting. By transmitting existing infection data from AICE to NHSN, AICE users reduce manual data entry to NHSN.

ICPA has been working with CDC and the HL7 Structured Document Technical Committee since June of 2006 to develop practical specifications for transmitting data to NHSN. "This new use of data standards will make it possible for hospitals to report crucial data to CDC using information technology systems in which they have already invested," said Denise Cardo, M.D., Director of CDC's Division of Healthcare Quality Promotion.

ICPA will participate in CDC's pilot tests planned for 2008 and continue to stay abreast of any and all changes to NHSN data requirements. "Our goal is to provide healthcare facilities the tools they need to prevent healthcare-associated infections and reduce the enormous human and financial toll these infections cause. Using AICE, Infection Control Professionals can produce confidential feedback reports internally, and use the same system to comply with mandatory state and/or national reporting requirements. In states requiring reporting to NHSN, AICE greatly decreases mandatory reporting data entry costs," said Deborah Martin, ICPA CEO.

ICPA's mission is to improve health and patient safety by providing software tools necessary to reduce the risks of infection and other adverse outcomes.

Contact Information